Navigation Links
Interleukin Genetics to Present at the 13th International Conference on Periodontal Research
Date:6/3/2008

Dr. Kenneth Kornman to Discuss Periodontal Inflammation and

Gene-Environment Interactions

WALTHAM, Mass., June 3 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI), announced today that Dr. Kenneth Kornman, Chief Scientific Officer, will present at the 13th International Conference on Periodontal Research (ICPR) on June 6, 2008 in Ljubljana, Slovenia on the genetic and environmental factors that control inflammation differences among individuals. The ICPR meeting has been held approximately every three years since 1969 to bring together the world's leaders in periodontal research to reassess the current knowledge in the field and to identify new research direction, to improve the diagnosis, prevention, and treatment of periodontal diseases.

Periodontitis is a bacterially-induced chronic inflammatory disease that causes destruction of bone and other tissues that support the teeth. Severe periodontitis, that usually leads to loss of multiple teeth, is found in approximately 8-13 percent of the adult population. The presence and severity of periodontitis have been associated with an increased risk for other important inflammatory conditions, including pre-term births, cardiovascular disease, rheumatoid arthritis, and certain cancers.

WHO: Dr. Kenneth Kornman, Chief Scientific Officer of Interleukin

Genetics

WHERE: 13th International Conference on Periodontal Research (ICPR) in

Ljubljana, Slovenia

WHEN: Friday, June 6, 2008 at 9:45-10:30 GMT

WHAT: Approximately 30-60 percent of the severity of periodontal disease

is determined by genetics. Interleukin Genetics developed and

markets the PST(R) genet
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)
2. Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
3. Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Business Results
4. Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer
5. Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results
6. Interleukin Genetics Retains Top Life Science Communications Firms
7. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
8. Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
9. Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
10. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
11. Interleukin Genetics Announces Management and Board Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Sept. 17, 2014 Intarcia Therapeutics, Inc. ... from a study of the cost and predictability of ... th Annual Meeting of the European Association for ... today, Christian Frois , Ph.D., of Analysis Group, ... of planned Intarcia-sponsored, retrospective studies to characterize the prevalence ...
(Date:9/17/2014)... Mass. , Sept. 17, 2014 ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today announced that it has been ... and Trademark Office on its unique delivery system ... ) to phagocytic cells for the treatment of ...
(Date:9/17/2014)... September 17, 2014 NASA’s MESSENGER has ... Engineering Corporation is proud to have one of its ... MESSENGER mission is a scientific investigation of the planet ... be sent there, and has provided a vast amount ... V27200 family of latch valves utilize solenoids that also ...
(Date:9/16/2014)... energy from jaw movements has been created by a ... that the device can generate electricity from eating, chewing ... or wearable electronic devices, such as hearing aids, cochlear ... first results of the device,s performance have been published ... Materials and Structures . , Jaw movements have proved ...
Breaking Biology Technology:Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 4Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 5RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 2RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 3RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 4'Smart material' chin strap harvests energy from chewing 2
... of Toronto has selected quantum physicist Sandu Popescu to receive ... to the field of quantum mechanics. Quantum mechanics is ... predictions such as the fact that any small particle, an ... same time, the story it tells us is so remote ...
... 24, 2011 Juventas Therapeutics is a privately-held, ... of cardiovascular disease.  The Company,s lead product, JVS-100, ... been shown to repair damaged tissue through recruitment ... injury, prevention of ongoing cell death and restoration ...
... Radius Health, Inc. ("Radius") today announced that the ... financing round, including $66 million in equity financing and ... Oxford Finance LLC to a $25 million multi-draw term ... Brookside Capital, Saints Capital, Nordic Bioscience ("Nordic"), and Ipsen ...
Cached Biology Technology:U of Toronto to award quantum mechanics prize to renowned physicist Sandu Popescu 2Juventas Therapeutics Demonstrates JVS-100 Delivery to Patients with Heart Failure is Safe and Provides Clinical Benefit 2Juventas Therapeutics Demonstrates JVS-100 Delivery to Patients with Heart Failure is Safe and Provides Clinical Benefit 3Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 2Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 3Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 4Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 5
(Date:9/16/2014)... us sick can take up residence in and on ... other troublesome symptom, according to new research at Washington ... On average, healthy individuals carry about five types of ... BioMed Central Biology . The study is the ... in healthy people. , The research was conducted ...
(Date:9/16/2014)... The fall marks a new school year, a new ... International Space Station. In September, SpaceX,s Dragon spacecraft is ... supplies and investigations as part of the company,s fourth ... cargo will be the third suite of research investigations ... in Space (CASIS). With the role of managing the ...
(Date:9/16/2014)... Scotland votes for independence later this week, its Government ... people that fracking is necessary, research has revealed. , ... tracking public perception of shale gas extraction in the ... living north of the border are the least supportive ... research in the University,s School of Geography, said: "The ...
Breaking Biology News(10 mins):Healthy humans make nice homes for viruses 2Healthy humans make nice homes for viruses 3CASIS research set for launch aboard SpaceX mission to space station 2CASIS research set for launch aboard SpaceX mission to space station 3Scottish people most sceptical on fracking, survey shows 2Scottish people most sceptical on fracking, survey shows 3
... in a recently discovered gene is the most ... The discovery by an,international research team provides fresh ... some cases of Parkinson's disease. The,findings could lead ... detect the,mutation in individuals at risk. The research ...
... For,everyone doing or reading a paper about microarray-based experiments,reproductibility, ... results? If I redo the same experiment in one ... recently demonstrated that microarrays experiments performed in different ... reproducibility , as long as standardized protocols are carefully ...
... present a “cautionary tale?about what may go wrong when using ... for cancer. , In the February 16 issue of the ... of Texas M. D. Anderson Cancer Center detail why an ... small sample of blood is unlikely to lead to a ...
Cached Biology News:Scientists detect probable genetic cause of some Parkinson's disease cases 2Scientists detect probable genetic cause of some Parkinson's disease cases 3Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible 2Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible 3New species from old data 2New species from old data 3
... Drummond Scientific has a long ... of microinjection apparatus. Several years ago ... positive displacement microdispenser was being modified ... this unit by redesigning the microdispenser ...
... power supply (Cat. No. Minis 150VS) is ... meet most electrophoresis needs in a personal, ... 150V power supply is capable of running ... designed for individuals to have his/her own ...
BD BioCoat Laminin 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse laminin....
... Expression is a powerful application for ... a novel interface, Expression makes complex ... simple. Expression uses the very latest ... in the way sequences are analysed. ...
Biology Products: